CSMD1 Mutations Are Associated with Increased Mutational Burden, Favorable Prognosis, and Anti-Tumor Immunity in Gastric Cancer

Tumor mutational burden (TMB) is considered a potential biomarker for predicting the response and effect of immune checkpoint inhibitors (ICIs). To find specific gene mutations related to TMB and the prognosis of patients, the frequently mutated genes in gastric cancer patients from TCGA and ICGC we...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Taobi, Liang, Yuan, Zhang, Huiyun, Chen, Xia, Wei, Hui, Sun, Weiming, Wang, Yuping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623648/
https://www.ncbi.nlm.nih.gov/pubmed/34828321
http://dx.doi.org/10.3390/genes12111715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623648/
https://www.ncbi.nlm.nih.gov/pubmed/34828321
http://dx.doi.org/10.3390/genes12111715

Ejemplares similares